DK159686C - Analogifremgangsmaade til fremstilling af 6alfa-methylcotikoider - Google Patents

Analogifremgangsmaade til fremstilling af 6alfa-methylcotikoider

Info

Publication number
DK159686C
DK159686C DK533783A DK533783A DK159686C DK 159686 C DK159686 C DK 159686C DK 533783 A DK533783 A DK 533783A DK 533783 A DK533783 A DK 533783A DK 159686 C DK159686 C DK 159686C
Authority
DK
Denmark
Prior art keywords
methyl
coticoids
6alfa
preparation
analogy procedure
Prior art date
Application number
DK533783A
Other languages
English (en)
Other versions
DK159686B (da
DK533783D0 (da
DK533783A (da
Inventor
Klaus Annen
Henry Laurent
Helmut Hofmeister
Rudolf Weichert
Hans Wendt
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK533783D0 publication Critical patent/DK533783D0/da
Publication of DK533783A publication Critical patent/DK533783A/da
Publication of DK159686B publication Critical patent/DK159686B/da
Application granted granted Critical
Publication of DK159686C publication Critical patent/DK159686C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Seasonings (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacture Of Tobacco Products (AREA)
DK533783A 1982-11-22 1983-11-22 Analogifremgangsmaade til fremstilling af 6alfa-methylcotikoider DK159686C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3243482 1982-11-22
DE19823243482 DE3243482A1 (de) 1982-11-22 1982-11-22 Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung

Publications (4)

Publication Number Publication Date
DK533783D0 DK533783D0 (da) 1983-11-22
DK533783A DK533783A (da) 1984-05-23
DK159686B DK159686B (da) 1990-11-19
DK159686C true DK159686C (da) 1991-04-15

Family

ID=6178924

Family Applications (1)

Application Number Title Priority Date Filing Date
DK533783A DK159686C (da) 1982-11-22 1983-11-22 Analogifremgangsmaade til fremstilling af 6alfa-methylcotikoider

Country Status (22)

Country Link
US (1) US4645763A (da)
EP (1) EP0110041B1 (da)
JP (1) JPS59106500A (da)
AT (1) ATE28651T1 (da)
AU (1) AU2098983A (da)
BG (2) BG43867A3 (da)
CA (1) CA1303607C (da)
CS (1) CS248712B2 (da)
DD (1) DD219200A5 (da)
DE (2) DE3243482A1 (da)
DK (1) DK159686C (da)
ES (1) ES526446A0 (da)
GB (1) GB2130587A (da)
GR (1) GR79725B (da)
HU (1) HU190746B (da)
IE (1) IE56281B1 (da)
IL (1) IL70160A (da)
NO (1) NO157454C (da)
PL (3) PL141686B1 (da)
PT (1) PT77408B (da)
RO (2) RO93593B (da)
ZA (1) ZA838720B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60161914A (ja) * 1984-02-02 1985-08-23 Green Cross Corp:The ステロイド脂肪酸エステル含有直腸投与製剤
JPS61274795A (ja) * 1985-05-30 1986-12-04 Toshiba Corp 曝気槽の溶存酸素濃度制御装置
US4968822A (en) * 1987-12-11 1990-11-06 Taisho Pharmaceutical Co., Ltd. 21-alkoxysteroid compounds
JPH05501115A (ja) * 1990-03-27 1993-03-04 シェリング・コーポレーション ９α―ヒドロキシ　ステロイドの脱水法
DE4333920A1 (de) * 1993-10-05 1995-04-13 Hoechst Ag Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
ITMI20011762A1 (it) 2001-08-10 2003-02-10 Cosmo Spa Esteri di 17alfa,21-diidrossipregnene, loro uso come agenti anti-androgenetici e procedimenti per la loro preparazione
ITMI20071616A1 (it) 2007-08-03 2009-02-04 Cosmo Spa Processo enzimatico per l'ottenimento di 17-alfa monoesteri del cortexolone e/o suoi 9,11-deidroderivati.
ES2548402T3 (es) 2008-05-28 2015-10-16 Reveragen Biopharma, Inc. Moduladores esteroideos no hormonales de NF-kappaB para el tratamiento de enfermedades
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
EP3108879A1 (en) 2015-06-25 2016-12-28 Cassiopea S.p.A. High concentration formulation
WO2017004205A1 (en) 2015-06-29 2017-01-05 Reveragen Biopharma, Inc. NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3053832A (en) * 1957-04-29 1962-09-11 Schering Corp Alkylated cortical steroids
GB921533A (en) * 1958-07-12 1963-03-20 Syntex Sa Cyclopentanophenanthrene derivatives and process for the production thereof
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
DE2645104C2 (de) * 1976-10-04 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen 11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung
US4243586A (en) * 1980-01-18 1981-01-06 E. R. Squibb & Sons, Inc. Steroidal-17-spiro-dihydrofuranones
US4336200A (en) * 1980-01-31 1982-06-22 The Upjohn Company 17α-Acyloxy-5β-corticoids
US4318853A (en) * 1980-01-31 1982-03-09 The Upjohn Company 9β,11β-Epoxy-5β-corticoids
DE3169460D1 (en) * 1980-12-23 1985-04-25 Schering Ag 6-alpha-methyl hydrocortisone derivatives, their preparation and their utilization

Also Published As

Publication number Publication date
US4645763A (en) 1987-02-24
IL70160A (en) 1988-03-31
IL70160A0 (en) 1984-02-29
ES8405421A1 (es) 1984-06-16
RO93593B (ro) 1988-01-01
EP0110041A1 (de) 1984-06-13
PL250734A1 (en) 1985-07-30
HU190746B (en) 1986-10-28
RO89343A (ro) 1986-03-15
DK159686B (da) 1990-11-19
GR79725B (da) 1984-10-31
PT77408A (de) 1983-10-01
PL141686B1 (en) 1987-08-31
RO93593A (ro) 1987-12-31
PL250735A1 (en) 1985-07-30
CS248712B2 (en) 1987-02-12
GB2130587A (en) 1984-06-06
ES526446A0 (es) 1984-06-16
BG43867A3 (en) 1988-08-15
PT77408B (de) 1986-02-27
DE3372776D1 (en) 1987-09-03
ATE28651T1 (de) 1987-08-15
JPS59106500A (ja) 1984-06-20
DK533783D0 (da) 1983-11-22
ZA838720B (en) 1984-07-25
GB8327736D0 (en) 1983-11-16
NO157454C (no) 1988-03-23
PL138796B1 (en) 1986-11-29
IE56281B1 (en) 1991-06-05
BG42677A3 (en) 1988-01-15
DE3243482A1 (de) 1984-05-24
JPH0415799B2 (da) 1992-03-19
NO157454B (no) 1987-12-14
NO834265L (no) 1984-05-23
AU2098983A (en) 1984-05-31
PL244685A1 (en) 1985-04-24
IE832708L (en) 1984-05-22
DD219200A5 (de) 1985-02-27
EP0110041B1 (de) 1987-07-29
CA1303607C (en) 1992-06-16
DK533783A (da) 1984-05-23

Similar Documents

Publication Publication Date Title
DK159686C (da) Analogifremgangsmaade til fremstilling af 6alfa-methylcotikoider
DK160505C (da) Analogifremgangsmaade til fremstilling af 6alfa-methylprednisolonderivater
AU548396B2 (en) 2-aryl-3,4-diazabicyclo(4.n.0)alk-2-en-5-ones
DK165364C (da) Fedtsyreestere, kosmetisk middel indeholdende disse og fremgangsmaade til fremstilling af saadanne estere
DK451282A (da) Fremgangsmaade til fremstilling af thiazolidinylestere af mineralsyrer
AU584098B2 (en) Substituted azabicycloheptanes, the use thereof, pharmaceutical preparations that contain these compounds, and processes for the manufacture of these compounds
ATE73136T1 (de) Verfahren zur herstellung von 6alpha, 9alphadifluor-11beta, 17alpha-dihydroxy-16alpha-methyl4-pregnen-3,20-dion und dessen derivate.
ES505328A0 (es) Procedimiento para la preparacion de cardenolido-bis-digoto-xosidos
DK496283D0 (da) Fremgangsmade til fremstilling af 7alfa-acylthio-1alfa,2alfamethylen-3-oxo-17-alfa-pregn-4-en-21,17-carbolactoner
DK146007C (da) Analogifremgangsmaade til fremstilling af d-homosteroider
SE7903971L (sv) Antitumordeoxiantracykliner
ES518417A0 (es) Un procedimiento para la preparacion de esteres fluorofenoxibencilicos.
DK400283A (da) Analogifremgangsmaade til fremstilling af 4'-deoxy-4'-ioddoxorubicin